Works matching IS 09395555 AND DT 2024 AND VI 103 AND IP 2


Results: 40
    1
    2
    3
    4
    5

    Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 451, doi. 10.1007/s00277-023-05582-y
    By:
    • Sobas, Marta;
    • Knopinska-Posluszny, Wanda;
    • Piątkowska-Jakubas, Beata;
    • García-Álvarez, Flor;
    • Díez, María Elena Amutio;
    • Caballero, Mar;
    • Martínez-Cuadrón, David;
    • Aguiar, Eliana;
    • González-Campos, Jose;
    • Garrido, Ana;
    • Algarra, Lorenzo;
    • Salamero, Olga;
    • de la Serna, Javier;
    • Sayas, Maria Jose;
    • Perez-Encinas, Manuel Mateo;
    • Vives, Susana;
    • Vidriales, Belén;
    • Labrador, Jorge;
    • Prado, Ana Inés;
    • Celebrin, Lucía
    Publication type:
    Article
    6
    7
    8
    9

    Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 437, doi. 10.1007/s00277-023-05577-9
    By:
    • Barbui, Tiziano;
    • Carobbio, Alessandra;
    • De Stefano, Valerio;
    • Alvarez-Larran, Alberto;
    • Ghirardi, Arianna;
    • Carioli, Greta;
    • Fenili, Francesca;
    • Rossi, Elena;
    • Ciceri, Fabio;
    • Bonifacio, Massimiliano;
    • Iurlo, Alessandra;
    • Palandri, Francesca;
    • Benevolo, Giulia;
    • Pane, Fabrizio;
    • Ricco, Alessandra;
    • Carli, Giuseppe;
    • Caramella, Marianna;
    • Rapezzi, Davide;
    • Musolino, Caterina;
    • Siragusa, Sergio
    Publication type:
    Article
    10
    11
    12

    The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
    By:
    • Mulas, Olga;
    • Abruzzese, Elisabetta;
    • Luciano, Luigiana;
    • Iurlo, Alessandra;
    • Attolico, Immacolata;
    • Castagnetti, Fausto;
    • Galimberti, Sara;
    • Bonifacio, Massimiliano;
    • Annunziata, Mario;
    • Gozzini, Antonella;
    • Orlandi, Ester Maria;
    • Stagno, Fabio;
    • Binotto, Gianni;
    • Pregno, Patrizia;
    • Fozza, Claudio;
    • Loi, Maurizio;
    • Trawinska, Malgorzata Monika;
    • De Gregorio, Fiorenza;
    • Cattaneo, Daniele;
    • Albano, Francesco
    Publication type:
    Article
    13
    14
    15
    16

    Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 609, doi. 10.1007/s00277-023-05542-6
    By:
    • Brusosa, Marc;
    • Ruiz, Sonia;
    • Monge, Inés;
    • Solano, María Teresa;
    • Rosiñol, Laura;
    • Esteve, Jordi;
    • Carreras, Enric;
    • Marcos, M. Ángeles;
    • Riu, Gisela;
    • Carcelero, Esther;
    • Martinez, Carmen;
    • Fernández-Avilés, Francesc;
    • Rovira, Montserrat;
    • Suárez-Lledó, María;
    • Salas, María Queralt
    Publication type:
    Article
    17

    Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 373, doi. 10.1007/s00277-023-05539-1
    By:
    • García-Morin, Marina;
    • Bardón-Cancho, Eduardo J.;
    • Beléndez, Cristina;
    • Dulín, Elena;
    • Blanco-Soto, Paula;
    • Puertas-López, Carolina;
    • Prieto-Medina, Mar;
    • Cervera-Bravo, Áurea;
    • Llorente-Otones, Lucía;
    • Pérez-Alonso, Vanesa;
    • San-Román, Sonsoles;
    • Vecilla-Rivelles, Cruz;
    • López-Rubio, Montserrat;
    • Sebastián, Elena;
    • Bellón, José M.;
    • Cela, Elena
    Publication type:
    Article
    18

    Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 385, doi. 10.1007/s00277-023-05555-1
    By:
    • Songdej, Duantida;
    • Surapolchai, Pacharapan;
    • Komwilaisak, Patcharee;
    • Sripornsawan, Pornpun;
    • Lauhasurayotin, Supanun;
    • Teawtrakul, Nattiya;
    • Rungjirajittranon, Tarinee;
    • Tantiworawit, Adisak;
    • Sinlapamongkolkul, Phakatip;
    • Torcharus, Kitti;
    • Sutcharitchan, Pranee;
    • Pongtanakul, Bunchoo;
    • Sirachainan, Nongnuch;
    • Charoenkwan, Pimlak
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 583, doi. 10.1007/s00277-023-05521-x
    By:
    • Fernandez-Luis, Sara;
    • Gomez Lamas, David;
    • Cerezo Martin, Juan Manuel;
    • Mora Barrios, Juan Manuel;
    • Yañez San Segundo, Lucrecia;
    • Sanchez Escamilla, Miriam;
    • Fernandez-Escalada, Noemi;
    • Calvo Sanchez, Jose Alvaro;
    • Fernandez Garcia, Sergio;
    • Dominguez-Garcia, Juan Jose;
    • Colorado Araujo, Mercedes;
    • Lopez-Duarte, Monica;
    • Martin-Sanchez, Guillermo;
    • Insunza Gaminde, Andres;
    • Romon Alonso, Jose Iñigo;
    • Lobeira Rubio, Rocio;
    • Arroyo Rodriguez, Jose Luis;
    • Rueda Ciller, Beatriz;
    • Hermosilla Fernandez, Mar;
    • Marco Betes, Victor
    Publication type:
    Article
    28
    29
    30
    31
    32

    CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 575, doi. 10.1007/s00277-023-05513-x
    By:
    • Wang, Tao;
    • Liu, Ping;
    • Xu, Lili;
    • Gao, Lei;
    • Ni, Xiong;
    • Tang, Gusheng;
    • Chen, Li;
    • Chen, Jie;
    • Wang, Libing;
    • Wang, Yang;
    • Fu, Weijia;
    • Yue, Wenqin;
    • Liu, Na;
    • Li, Ruobing;
    • Lu, Guihua;
    • Luo, Yanrong;
    • Yang, Jianmin
    Publication type:
    Article
    33

    Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 663, doi. 10.1007/s00277-023-05505-x
    By:
    • Savani, Saloni;
    • Chennapragada, Suma Sri;
    • Ramphul, Kamleshun;
    • Dandwani, Mehndi;
    • Verma, Renuka;
    • Sanikommu, Sailaja;
    • Pagidipally, Alekhya;
    • Arti, FNU;
    • Kumar, Vijay;
    • Sombans, Shaheen;
    • Ramphul, Yogeshwaree;
    • Mejias, Stephanie G.;
    • Dhillon, Balkiranjit Kaur;
    • Lohana, Petras;
    • Sharma, Shivani
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 475, doi. 10.1007/s00277-023-05428-7
    By:
    • Horigome, Yuichi;
    • Iino, Masaki;
    • Harazaki, Yoriko;
    • Kobayashi, Takahiro;
    • Handa, Hiroshi;
    • Hiramatsu, Yasushi;
    • Kuroi, Taiga;
    • Tanimoto, Kazuki;
    • Matsue, Kosei;
    • Abe, Masahiro;
    • Ishida, Tadao;
    • Ito, Shigeki;
    • Iwasaki, Hiromi;
    • Kuroda, Junya;
    • Shibayama, Hirohiko;
    • Sunami, Kazutaka;
    • Takamatsu, Hiroyuki;
    • Tamura, Hideto;
    • Hayashi, Toshiaki;
    • Akagi, Kiwamu
    Publication type:
    Article